Virax Biolabs Group Limited Made Headway
Virax Biolabs Group Limited (VRAX:NASDAQ) jumped higher at $5.15, representing a gain of 141.8%. On Mon, Aug 19, 2024, VRAX:NASDAQ hit a New 2-Week High of $5.15. The stock appeared on our News Catalysts scanner on Fri, Aug 16, 2024 at 04:32 AM in the 'PUBLIC OFFERING' category. From Mon, Aug 05, 2024, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Mon, Aug 19, 2024 at $9 with a volume of 93M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Alzamend Neuro Inc. (ALZN:NASDAQ), 188.18%
- NuCana plc (NCNA:NASDAQ), 181.16%
- Unico American Corporation (UNAM:NASDAQ), 150%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 141.78%
- Sonder Holdings Inc. (SOND:NASDAQ), 130.53%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 128.64%
- SRAX, Inc. (SRAX:NASDAQ), 56%
- Telomir Pharmaceuticals Inc. (TELO:NASDAQ), 52.88%
- Electra Battery Materials Corporation (ELBM:NASDAQ), 50.24%
- Maxeon Solar Technologies Ltd. (MAXN:NASDAQ), 46.17%